Yoshihito Uchida
Publication Activity (10 Years)
Years Active: 2019-2024
Publications (10 Years): 15
Publications (10 Years): 15
Publications
- Daisuke Ito, Satoshi Shimizu, Akifumi Haisa, Shinnosuke Yanagisawa, Kazuyuki Inoue, Daigo Saito, Takashi Sumita, Morifumi Yanagisawa, Yoshihito Uchida, Kouichi Inukai, Akira ShimadaLong-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD. Journal of diabetes investigation 15 (9) (2024)
- Daisuke Ito, Satoshi Shimizu, Akifumi Haisa, Shinnosuke Yanagisawa, Kazuyuki Inoue, Daigo Saito, Takashi Sumita, Morifumi Yanagisawa, Yoshihito Uchida, Kouichi Inukai, Akira ShimadaLong-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD. Journal of diabetes investigation 15 (9) (2024)
- Daisuke Ito, Satoshi Shimizu, Akifumi Haisa, Shinnosuke Yanagisawa, Kazuyuki Inoue, Daigo Saito, Takashi Sumita, Morifumi Yanagisawa, Yoshihito Uchida, Kouichi Inukai, Akira ShimadaLong-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD. Journal of diabetes investigation 15 (9) (2024)
- Daisuke Ito, Satoshi Shimizu, Akifumi Haisa, Shinnosuke Yanagisawa, Kazuyuki Inoue, Daigo Saito, Takashi Sumita, Morifumi Yanagisawa, Yoshihito Uchida, Kouichi Inukai, Akira ShimadaLong-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD. Journal of diabetes investigation (2024)
- Shunsuke Yamada, Yoshihito Uchida, Jun-Ichi Kouyama, Kayoko Naiki, Shohei Tsuji, Hayato Uemura, Kayoko Sugawara, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Suguru Mizuno, Satoshi MochidaSwitching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
- Yoshihito Uchida, Yukinori Imai, Shohei Tsuji, Hayato Uemura, Jun-Ichi Kouyama, Kayoko Naiki, Satsuki Ando, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Suguru Mizuno, Tomoaki Tomiya, Satoshi MochidaSignificance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir. Hepatology research : the official journal of the Japan Society of Hepatology (2023)
- Hideto Kawaratani, Yasuteru Kondo, Ryoji Tatsumi, Naoto Kawabe, Norikazu Tanabe, Akira Sakamaki, Kazuo Okumoto, Yoshihito Uchida, Kei Endo, Takumi Kawaguchi, Tsunekazu Oikawa, Yoji Ishizu, Shuhei Hige, Taro Takami, Shuji Terai, Yoshiyuki Ueno, Satoshi Mochida, Yasuhiro Takikawa, Takuji Torimura, Tomokazu Matsuura, Masatoshi Ishigami, Kazuhiko Koike, Hitoshi Yoshiji
- Yoshihito Uchida, Masamitsu Nakao, Shunsuke Yamada, Shohei Tsuji, Hayato Uemura, Jun-Ichi Kouyama, Kayoko Naiki, Kayoko Sugawara, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida
- Yoshihito Uchida, Hayato Uemura, Shohei Tsuji, Shunsuke Yamada, Jun-Ichi Kouyama, Kayoko Naiki, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida
- Yoshihito Uchida, Mie Inao, Shohei Tsuji, Hayato Uemura, Jun-Ichi Kouyama, Kayoko Naiki, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida
- Yoshihito Uchida, Shohei Tsuji, Hayato Uemura, Jun-Ichi Kouyama, Kayoko Naiki, Kayoko Sugawara, Masamitsu Nakao, Mie Inao, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida
- Shohei Tsuji, Yoshihito Uchida, Hayato Uemura, Jun-Ichi Kouyama, Kayoko Naiki, Masamitsu Nakao, Daisuke Motoya, Kayoko Sugawara, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida
- Yoshihito Uchida, Masamitsu Nakao, Shohei Tsuji, Hayato Uemura, Jun-Ichi Kouyama, Kayoko Naiki, Daisuke Motoya, Kayoko Sugawara, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida
- Yoshihito Uchida, Jun-Ichi Kouyama, Kayoko Naiki, Hayato Uemura, Shohei Tsuji, Kayoko Sugawara, Masamitsu Nakao, Daisuke Motoya, Nobuaki Nakayama, Yukinori Imai, Tomoaki Tomiya, Satoshi Mochida
- Masamitsu Nakao, Nobuaki Nakayama, Yoshihito Uchida, Tomoaki Tomiya, Makoto Oketani, Akio Ido, Hirohito Tsubouchi, Hajime Takikawa, Satoshi MochidaDeteriorated outcome of recent patients with acute liver failure and late-onset hepatic failure caused by infection with hepatitis A virus: A subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan. Hepatology research : the official journal of the Japan Society of Hepatology 49 (8) (2019)